Company profile: Oval Medical Technologies
1.1 - Company Overview
Company description
- Provider of specialty pharmaceutical autoinjector platforms: ArQ subcutaneous two-step autoinjector with audible feedback, compatible with various viscosities, volumes, and needle gauges; Bios platform for large-volume, ultra-high viscosity formulations using ISO-standard plunger stoppers and staked-needle syringes; Vita resuspension platform for delivering large volumes with a dry-needle system for long-acting formulations.
Products and services
- Bios subcutaneous platform: An industrial-grade autoinjector engineered for large-volume, ultra-high viscosity formulations, utilizing ISO-standard plunger stoppers and staked-needle syringes for reliable subcutaneous delivery
- ArQ subcutaneous platform: An ergonomic, two-step user interface autoinjector with audible feedback, compatible with various viscosities, volumes, and configurable needle gauge options for precise subcutaneous administration
- Vita resuspension platform: A custom-engineered system delivering large volumes via resuspension technology and a dry-needle setup, suitable for long-acting formulations with configurable needle gauge and length
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Oval Medical Technologies
CeQur
HQ: Switzerland
Website
- Description: Provider of wearable insulin delivery solutions for people with diabetes, including the CeQur Simplicity insulin patch that delivers mealtime bolus insulin via a small, flexible cannula without injections. Offers a Patient Starter Kit with patches and a reusable inserter, the CeQur Cares support program, and the CeQur Simplicity Copay Savings Card. Works with physicians and centers to bring technology to patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CeQur company profile →
Credence MedSystems
HQ: United States
Website
- Description: Provider of drug delivery and specialty pharmaceutical solutions focused on safe medication administration, offering syringe systems including the Companion Safety Syringe with end-of-dose cues, passive needlestick safety, reuse prevention and pre-attached needle; Dual Chamber Reconstitution Syringe; Credence Connect for real-time injection monitoring; Micro-Dose Syringe for ocular use; and Multi-Site Syringe.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Credence MedSystems company profile →
Sedana Medical
HQ: Sweden
Website
- Description: Provider of anaesthetic delivery systems and agents, including the AnaConDa (Anaesthetic Conserving Device) for delivering anaesthetic agents during medical procedures; Sedaconda (isoflurane) for sedation with AnaConDa; Sedasource for continuous anaesthetic agent supply; and FlurAbsorb to absorb and manage anaesthetic gases in medical settings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sedana Medical company profile →
Lipocine
HQ: United States
Website
- Description: Provider of specialty pharmaceutical products, including TLANDO, an FDA-approved oral testosterone replacement therapy; LPCN 1111, an oral testosterone prodrug for hypogonadal men; LPCN 1144 and 1148, oral prodrugs of bioidentical testosterone for NASH and cirrhosis symptoms; LPCN 1107, an oral candidate to prevent recurrent preterm birth (FDA orphan drug); and LPCN 1154, an oral neurosteroid for postpartum depression.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lipocine company profile →
Suono Bio
HQ: United States
Website
- Description: Provider of ultrasound-mediated drug delivery platforms enabling ultra-rapid delivery of small molecules, biologics, and nucleic acids to the gastrointestinal tract and directly into cells without encapsulation; offerings include Ultrasonic Enhanced Delivery and SuonoCalm for treating inflammatory conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Suono Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Oval Medical Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Oval Medical Technologies
2.2 - Growth funds investing in similar companies to Oval Medical Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Oval Medical Technologies
4.2 - Public trading comparable groups for Oval Medical Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →